Zoetis Showcases R&D Strength and Growth in Animal Health
PARSIPPANY, N.J., December 3, 2025 — Zoetis has highlighted its R&D leadership, expanding innovation strategy, and long-term growth outlook...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
PARSIPPANY, N.J., December 3, 2025 — Zoetis has highlighted its R&D leadership, expanding innovation strategy, and long-term growth outlook...
Dateline IntroductionNovember 17, 2025 — Vancouver, BC & Austin, TX — Augurex Life Sciences Corp. announced the launch of...
NEW YORK, November 3, 2025 — CS Interpharm and CS Diagnostics Pharma (CSDX) have announced the completion of a...
CINCINNATI, OHIO, September 16, 2025 – Meridian Bioscience, Inc., a global leader in diagnostics and life science raw materials,...
